INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 445m ago
HOUSE PTR45m ago
SEC 13F45m ago
ROBINHOOD CHAIN44m ago
SEC FORM 4/Open-market saleVerified data

Mulshine Brendan Martin sold RYAN

Co-President and CRO · RYAN SPECIALTY HOLDINGS, INC. · Class A Common Stock

Side
SELL
Value
$1.62M
Shares
40.0K
Price
$40.51
Executed
Sep 8, 2026
Disclosed
Sep 9, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Sep 8 executedSep 9, 2026 disclosed

RYAN · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
38/ 100 · ELEVATED
Methodology →
  • Transaction type+12 / 20

    Open-market sale

  • Relative size+18 / 25

    $1.6M reported value · 34.7% of prior position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · RYAN

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    19
    MM
    Mulshine Brendan MartinCo-President and CRO
    RYANRYAN SPECIALTY HOLDINGS, INC.
    Derivative conversion
    		C—
    40.0K sh
    		Sep 4, 2026Sep 9, 2026
    traded Sep 4, 2026
    		+5dSEC FORM 4

    Evidence

    27
    MM
    Mulshine Brendan MartinCo-President and CRO
    RYANRYAN SPECIALTY HOLDINGS, INC.
    Derivative conversion
    		C—
    40.0K sh
    		Sep 4, 2026Sep 9, 2026
    traded Sep 4, 2026
    		+5dSEC FORM 4

    Evidence

    19
    MM
    Mulshine Brendan MartinCo-President and CRO
    RYANRYAN SPECIALTY HOLDINGS, INC.
    Derivative conversion
    		C—
    40.0K sh
    		Sep 4, 2026Sep 9, 2026
    traded Sep 4, 2026
    		+5dSEC FORM 4

    Evidence

    32
    CM
    Conklin MichaelEVP & CHRO
    RYANRYAN SPECIALTY HOLDINGS, INC.
    Open-market sale
    		SELL$86K
    2,043 sh
    		Aug 13, 2026Aug 14, 2026
    traded Aug 13, 2026
    		+1dSEC FORM 4

    Evidence

    50
    KJ
    Kuczinski Anthony JDirector
    RYANRYAN SPECIALTY HOLDINGS, INC.
    Open-market purchase
    		BUY$87K
    2,500 sh
    		Jun 11, 2026Jun 15, 2026
    traded Jun 11, 2026
    		+4dSEC FORM 4

    Evidence

    35
    KJ
    Kuczinski Anthony JDirector
    RYANRYAN SPECIALTY HOLDINGS, INC.
    Open-market purchase
    		BUY$18K
    500 sh
    		Jun 12, 2026Jun 15, 2026
    traded Jun 12, 2026
    		+3dSEC FORM 4

    Evidence

    54
    KS
    Katz Mark StephenEVP & General Counsel
    RYANRYAN SPECIALTY HOLDINGS, INC.
    Open-market purchase
    		BUY$100K
    3,215 sh
    		Jun 3, 2026Jun 4, 2026
    traded Jun 3, 2026
    		+1dSEC FORM 4

    Evidence

    54
    HM
    Hamilton Janice MChief Financial Officer
    RYANRYAN SPECIALTY HOLDINGS, INC.
    Open-market purchase
    		BUY$200K
    6,300 sh
    		Jun 3, 2026Jun 4, 2026
    traded Jun 3, 2026
    		+1dSEC FORM 4

    Evidence

    9
    WM
    Wuller Benjamin MIlesCEO RSUM
    RYANRYAN SPECIALTY HOLDINGS, INC.
    Grant or award
    		A—
    33.7K sh
    		May 5, 2026May 6, 2026
    traded May 5, 2026
    		+1dSEC FORM 4

    Evidence

    5
    TW
    Turner Timothy WilliamDirector, Chief Executive Officer
    RYANRYAN SPECIALTY HOLDINGS, INC.
    Grant or award
    		A—
    168.6K sh
    		May 5, 2026May 6, 2026
    traded May 5, 2026
    		+1dSEC FORM 4

    Evidence

    9
    KS
    Katz Mark StephenEVP & General Counsel
    RYANRYAN SPECIALTY HOLDINGS, INC.
    Grant or award
    		A—
    33.7K sh
    		May 5, 2026May 6, 2026
    traded May 5, 2026
    		+1dSEC FORM 4

    Evidence

    9
    MM
    Mulshine Brendan MartinCo-President and CRO
    RYANRYAN SPECIALTY HOLDINGS, INC.
    Grant or award
    		A—
    33.7K sh
    		May 5, 2026May 6, 2026
    traded May 5, 2026
    		+1dSEC FORM 4

    Evidence

    9
    HM
    Hamilton Janice MChief Financial Officer
    RYANRYAN SPECIALTY HOLDINGS, INC.
    Grant or award
    		A—
    33.7K sh
    		May 5, 2026May 6, 2026
    traded May 5, 2026
    		+1dSEC FORM 4

    Evidence

    21
    CD
    Cortezi Nicholas DominicDirector
    RYANRYAN SPECIALTY HOLDINGS, INC.
    Grant or award
    		A—
    5,757 sh
    		Apr 28, 2026Apr 30, 2026
    traded Apr 28, 2026
    		+2dSEC FORM 4

    Evidence

    21
    CF
    Cornelli FrancescaDirector
    RYANRYAN SPECIALTY HOLDINGS, INC.
    Grant or award
    		A—
    5,757 sh
    		Apr 28, 2026Apr 30, 2026
    traded Apr 28, 2026
    		+2dSEC FORM 4

    Evidence

    21
    KJ
    Kuczinski Anthony JDirector
    RYANRYAN SPECIALTY HOLDINGS, INC.
    Grant or award
    		A—
    5,757 sh
    		Apr 28, 2026Apr 30, 2026
    traded Apr 28, 2026
    		+2dSEC FORM 4

    Evidence

    9
    HM
    Hamilton Janice MChief Financial Officer
    RYANRYAN SPECIALTY HOLDINGS, INC.
    Grant or award
    		A—
    29.8K sh
    		Mar 3, 2026Mar 5, 2026
    traded Mar 3, 2026
    		+2dSEC FORM 4

    Evidence

    9
    WM
    Wuller Benjamin MIlesCEO RSUM
    RYANRYAN SPECIALTY HOLDINGS, INC.
    Grant or award
    		A—
    24.9K sh
    		Mar 3, 2026Mar 5, 2026
    traded Mar 3, 2026
    		+2dSEC FORM 4

    Evidence

    9
    KP
    Keogh Stephen PatrickCo-President and COO
    RYANRYAN SPECIALTY HOLDINGS, INC.
    Grant or award
    		A—
    24.9K sh
    		Mar 3, 2026Mar 5, 2026
    traded Mar 3, 2026
    		+2dSEC FORM 4

    Evidence

    9
    TW
    Turner Timothy WilliamDirector, Chief Executive Officer
    RYANRYAN SPECIALTY HOLDINGS, INC.
    Option exercise
    		M—
    222.0K sh
    		Dec 11, 2025Dec 15, 2025
    traded Dec 11, 2025
    		+4dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001869959-26-000006
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Sep 8, 2026
    Published
    Sep 9, 2026
    Ingested by INSIDER
    Nov 5, 02:18 UTC
    Last re-read
    Nov 5, 02:18 UTC

    Extracted facts

    Filer
    Mulshine Brendan Martin
    Role
    Co-President and CRO
    Transaction
    Open-market saleAs filed: “S”
    Asset
    RYAN SPECIALTY HOLDINGS, INC.
    Ticker
    RYAN
    Shares
    40.0K
    Price per share
    $40.51
    Value
    $1,620,320
    Execution date (reported)
    Sep 8, 2026
    Owned after transaction
    75.4K shares
    Days from execution to publication
    1

    Calculation

    Value = shares × reported price per share

    • Shares: 40.0K
    • Price: $40.508

    = $1,620,320

    What this establishes

    Mulshine Brendan Martin filed this Form 4 reporting a open-market sale of RYAN on Sep 8, 2026. It became public on Sep 9, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Co-President and CRO
    Mulshine Brendan Martincik:0001869959
    Issuer
    RYAN SPECIALTY HOLDINGS, INC.cik:0001849253

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.